Tapewire

NYSE · USD

HCA

HCA Healthcare, Inc.

Export transactions ↓
Tapewire entity
2929
SEC CIK
0000860730
Parsed reports
883

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 2026012
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 18, 2024 Filed Mar 20, 2024 17:16 UTC
Wasserman Chad JSVP and CIO
Tax withholdingCommon Stock 1,224 $327.17 $400,456.08
Disclosure

SEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 2

Wasserman Chad J · CIK 0002010252 · SVP and CIO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,796.3102

F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.

Read SEC document
March 18, 2024 Filed Mar 20, 2024 17:16 UTC
Wasserman Chad JSVP and CIO
Exercise / conversionCommon Stock 2,100 $101.16 $212,436.00
Disclosure

SEC source: 0001209191-24-004999 · doc4.xml · nonDerivative · entry 1

Wasserman Chad J · CIK 0002010252 · SVP and CIO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,020.3102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:36 UTC
Wyatt Christopher F.SVP & Controller
Tax withholdingCommon Stock 1,976 $308.55 $609,694.80
Disclosure

SEC source: 0001209191-24-003757 · doc4.xml · nonDerivative · entry 2

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,427

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:36 UTC
Wyatt Christopher F.SVP & Controller
GrantCommon Stock 5,020 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003757 · doc4.xml · nonDerivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,403

F1 · kind: On February 3, 2021, the reporting person was granted 2,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:35 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
Tax withholdingCommon Stock 1,023 $308.55 $315,646.65
Disclosure

SEC source: 0001209191-24-003756 · doc4.xml · nonDerivative · entry 2

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,658

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:35 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
GrantCommon Stock 3,780 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003756 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,681

F1 · kind: On February 3, 2021, the reporting person was granted 1,890 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:35 UTC
Wasserman Chad JSVP and CIO
Tax withholdingCommon Stock 499 $308.55 $153,966.45
Disclosure

SEC source: 0001209191-24-003755 · doc4.xml · nonDerivative · entry 2

Wasserman Chad J · CIK 0002010252 · SVP and CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,920.3102

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:35 UTC
Wasserman Chad JSVP and CIO
GrantCommon Stock 2,040 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003755 · doc4.xml · nonDerivative · entry 1

Wasserman Chad J · CIK 0002010252 · SVP and CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,419.3102

F1 · kind: On February 3, 2021, the reporting person was granted 1,020 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:34 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
Tax withholdingCommon Stock 1,976 $308.55 $609,694.80
Disclosure

SEC source: 0001209191-24-003754 · doc4.xml · nonDerivative · entry 2

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,338

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:34 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
GrantCommon Stock 5,020 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003754 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,314

F1 · kind: On February 3, 2021, the reporting person was granted 2,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:34 UTC
Sowell Joseph A IIISVP; Chief Development Officer
Tax withholdingCommon Stock 2,005 $308.55 $618,642.75
Disclosure

SEC source: 0001209191-24-003753 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,275

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:34 UTC
Sowell Joseph A IIISVP; Chief Development Officer
GrantCommon Stock 6,280 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003753 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,280

F1 · kind: On February 3, 2021, the reporting person was granted 3,140 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:33 UTC Tax withholdingCommon Stock 8,177 $308.55 $2,523,013.35
Disclosure

SEC source: 0001209191-24-003752 · doc4.xml · nonDerivative · entry 2

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,251

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:33 UTC GrantCommon Stock 21,980 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003752 · doc4.xml · nonDerivative · entry 1

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,428

F1 · kind: On February 3, 2021, the reporting person was granted 10,990 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:32 UTC
Reiner Deborah MSVP - Mktg. & Communications
Tax withholdingCommon Stock 1,510 $308.55 $465,910.50
Disclosure

SEC source: 0001209191-24-003751 · doc4.xml · nonDerivative · entry 2

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,824

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:32 UTC
Reiner Deborah MSVP - Mktg. & Communications
GrantCommon Stock 5,020 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003751 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,334

F1 · kind: On February 3, 2021, the reporting person was granted 2,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:32 UTC
Mosier Sammie SSVP & Chief Nurse Executive
Tax withholdingCommon Stock 1,068 $308.55 $329,531.40
Disclosure

SEC source: 0001209191-24-003750 · doc4.xml · nonDerivative · entry 3

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,398

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:32 UTC
Mosier Sammie SSVP & Chief Nurse Executive
GrantCommon Stock 1,620 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003750 · doc4.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,466

F2 · kind: On October 25, 2021, the reporting person was granted 810 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:32 UTC
Mosier Sammie SSVP & Chief Nurse Executive
GrantCommon Stock 2,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003750 · doc4.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,846

F1 · kind: On February 3, 2021, the reporting person was granted 1,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:32 UTC
McManus Timothy MGroup President
Tax withholdingCommon Stock 2,002 $308.55 $617,717.10
Disclosure

SEC source: 0001209191-24-003749 · doc4.xml · nonDerivative · entry 2

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,427.4141

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:32 UTC
McManus Timothy MGroup President
GrantCommon Stock 6,280 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003749 · doc4.xml · nonDerivative · entry 1

McManus Timothy M · CIK 0001957740 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,429.4141

F1 · kind: On February 3, 2021, the reporting person was granted 3,140 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:31 UTC
Marks Mike ASVP-Finance
Tax withholdingCommon Stock 1,022 $308.55 $315,338.10
Disclosure

SEC source: 0001209191-24-003748 · doc4.xml · nonDerivative · entry 2

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,803

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:31 UTC
Marks Mike ASVP-Finance
GrantCommon Stock 3,780 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003748 · doc4.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · SVP-Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,825

F1 · kind: On February 3, 2021, the reporting person was granted 1,890 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:31 UTC
HAZEN SAMUEL NDirector · CEO
Tax withholdingCommon Stock 30,387 $308.55 $9,375,908.85
Disclosure

SEC source: 0001209191-24-003747 · doc4.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,744

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:31 UTC
HAZEN SAMUEL NDirector · CEO
GrantCommon Stock 78,440 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003747 · doc4.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,131

F1 · kind: On February 3, 2021, the reporting person was granted 39,220 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested at 11:01 p.m. Central Time on February 16, 2024 equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:30 UTC
Hammett Richard AGroup President
Tax withholdingCommon Stock 1,762 $308.55 $543,665.10
Disclosure

SEC source: 0001209191-24-003745 · doc4.xml · nonDerivative · entry 2

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,936

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:30 UTC
Hammett Richard AGroup President
GrantCommon Stock 5,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003745 · doc4.xml · nonDerivative · entry 1

Hammett Richard A · CIK 0001957822 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,698

F1 · kind: On February 3, 2021, the reporting person was granted 2,750 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:29 UTC
Foster Jon MEVP and COO
Tax withholdingCommon Stock 5,950 $308.55 $1,835,872.50
Disclosure

SEC source: 0001209191-24-003744 · doc4.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,830

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:29 UTC
Foster Jon MEVP and COO
GrantCommon Stock 16,320 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003744 · doc4.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,780

F1 · kind: On February 3, 2021, the reporting person was granted 8,160 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:29 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
Tax withholdingCommon Stock 6,212 $308.55 $1,916,712.60
Disclosure

SEC source: 0001209191-24-003743 · doc4.xml · nonDerivative · entry 3

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,696.9672

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:29 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
GrantCommon Stock 4,420 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003743 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,908.9672

F2 · kind: On October 25, 2021, the reporting person was granted 2,210 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:29 UTC
Cuffe Michael S.EVP and Chief Clinical Officer
GrantCommon Stock 12,560 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003743 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,488.9672

F1 · kind: On February 3, 2021, the reporting person was granted 6,280 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:28 UTC
Cohen Jeffrey E.SVP-Government Relations
Tax withholdingCommon Stock 1,359 $308.55 $419,319.45
Disclosure

SEC source: 0001209191-24-003742 · doc4.xml · nonDerivative · entry 2

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,835

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:28 UTC
Cohen Jeffrey E.SVP-Government Relations
GrantCommon Stock 3,780 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003742 · doc4.xml · nonDerivative · entry 1

Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,194

F1 · kind: On February 3, 2021, the reporting person was granted 1,890 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:27 UTC
Billington Phillip GSVP-Internal Audit Services
Tax withholdingCommon Stock 1,022 $308.55 $315,338.10
Disclosure

SEC source: 0001209191-24-003741 · doc4.xml · nonDerivative · entry 2

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,618.4544

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:27 UTC
Billington Phillip GSVP-Internal Audit Services
GrantCommon Stock 3,780 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003741 · doc4.xml · nonDerivative · entry 1

Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,640.4544

F1 · kind: On February 3, 2021, the reporting person was granted 1,890 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:27 UTC
Berres JenniferSVP & Chief Human Res. Officer
Tax withholdingCommon Stock 3,240 $308.55 $999,702.00
Disclosure

SEC source: 0001209191-24-003739 · doc4.xml · nonDerivative · entry 2

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,731

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:27 UTC
Berres JenniferSVP & Chief Human Res. Officer
GrantCommon Stock 9,420 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003739 · doc4.xml · nonDerivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,971

F1 · kind: On February 3, 2021, the reporting person was granted 4,710 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:26 UTC
Akdamar Erol RGroup President
Tax withholdingCommon Stock 2,561 $308.55 $790,196.55
Disclosure

SEC source: 0001209191-24-003738 · doc4.xml · nonDerivative · entry 2

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,139

Read SEC document
February 16, 2024 Filed Feb 21, 2024 19:26 UTC
Akdamar Erol RGroup President
GrantCommon Stock 7,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003738 · doc4.xml · nonDerivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,700

F1 · kind: On February 3, 2021, the reporting person was granted 3,850 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 17:58 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
GiftCommon Stock 349 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003460 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,901

Read SEC document
February 09, 2024 Filed Feb 13, 2024 19:03 UTC
Whalen Kathleen MSVP & Chief Ethics Officer
SaleCommon Stock 4,262 $306.21 $1,305,074.27
Disclosure

SEC source: 0001209191-24-003242 · doc4.xml · nonDerivative · entry 1

Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,250

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.16 to $306.34, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 06, 2024 Filed Feb 6, 2024 18:34 UTC SaleCommon Stock 6,000 $310.63 $1,863,780.00
Disclosure

SEC source: 0001209191-24-002937 · doc4.xml · nonDerivative · entry 6

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,448

Read SEC document
February 06, 2024 Filed Feb 8, 2024 19:13 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
Exercise / conversionStock Appreciation Right · Derivative 2,092 $0.00 Strike: $173.12 $0.00
Disclosure

SEC source: 0001209191-24-003003 · doc4.xml · derivative · entry 3

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,093

Underlying: Common Stock · 2,092 shares

Expires 2031-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 19:13 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
Tax withholdingCommon Stock 1,423 $306.82 $436,604.86
Disclosure

SEC source: 0001209191-24-003003 · doc4.xml · nonDerivative · entry 2

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,294

Read SEC document
February 06, 2024 Filed Feb 8, 2024 19:13 UTC
Torres Kathryn A.SVP-Payer Contracting & Align.
Exercise / conversionCommon Stock 2,092 $173.12 $362,167.04
Disclosure

SEC source: 0001209191-24-003003 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2024 Filed Feb 8, 2024 19:13 UTC
Akdamar Erol RGroup President
GiftCommon Stock 12,874 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003002 · doc4.xml · nonDerivative · entry 2

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 55,358

Read SEC document
February 06, 2024 Filed Feb 8, 2024 19:13 UTC
Akdamar Erol RGroup President
GiftCommon Stock 12,874 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003002 · doc4.xml · nonDerivative · entry 1

Akdamar Erol R · CIK 0001957739 · Group President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
February 05, 2024 Filed Feb 6, 2024 18:34 UTC GiftCommon Stock 1,194 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002937 · doc4.xml · nonDerivative · entry 5

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 19,834

Read SEC document
February 05, 2024 Filed Feb 6, 2024 18:34 UTC GiftCommon Stock 1,194 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002937 · doc4.xml · nonDerivative · entry 4

RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,448

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.